![]() | Up a level |
Rao, Christopher, Myint, Arthur Sun, Athanasiou, Thanos, Faiz, Omar, Martin, Antony Paul ORCID: 0000-0003-4383-6038, Collins, Brendan
ORCID: 0000-0002-3023-8189 and Smith, Fraser McLean
(2017)
Avoiding Radical Surgery in Elderly Patients With Rectal Cancer Is Cost-Effective.
, United States.
Myint, Arthur Sun, Smith, Fraser McLean, Gollins, Simon, Wong, Helen, Rao, Christopher, Whitmarsh, Karen, Sripadam, Raj, Rooney, Paul, Hershman, Michael and Pritchard, D Mark ORCID: 0000-0001-7971-3561
(2018)
Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
International Journal of Radiation: Oncology - Biology - Physics, 100 (3).
pp. 565-573.
Myint, Arthur Sun, Smith, Fraser McLean, Gollins, Simon William, Wong, Helen, Rao, Christopher, Whitmarsh, Karen, Sripadam, Raj, Rooney, Paul, Hershman, Michael Jeremy, Fekete, Zsolt et al (show 2 more authors)
(2017)
Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
BRITISH JOURNAL OF RADIOLOGY, 90 (1080).
20170175-.
Rao, Christopher, Lean Smith, Fraser Mc, Martin, Antony Paul ORCID: 0000-0003-4383-6038, Dhadda, Amandeep, Stewart, Alexandra, Gollins, Simon, Collins, Brendan
ORCID: 0000-0002-3023-8189, Athanasiou, Thanos and Myint, Arthur Sun
(2017)
A cost-effectiveness analysis of contact x-ray brachytherapy for treatment of patients with a partial response to chemoradiotherapy for locally advanced rectal cancer.
In: NCRI Cancer Conference.
Sun Myint, Arthur ORCID: 0000-0001-5323-5696, Rao, Christopher, Barbet, Nicolas, Thamphya, Brice, Pace-Loscos, Tanguy, Schiappa, Renaud, Magné, Nicolas, Martel-Lafay, Isabelle, Mineur, Laurent, Deberne, Melanie et al (show 3 more authors)
(2023)
The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 25 (11).
pp. 2160-2169.